Noninvasive Technique and High Flow Nasal Oxygen in Respiratory Failure

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMinia University

About this trial

After obtaining Institutional Ethical Committee approval of Faculty of Medicine, Minia University and written informed consent from patients or first- degree relatives, this prospective randomized non-blind comparative study will be conducted in adult intensive care unit (ICU) of Anesthesia, Intensive Care and Pain management department Minia university hospital over a period from September 2025 to April 2026. This study is designed to compare the effectiveness of two protocols of sequential use of High Flow Nasal Cannula (HFNC) and noninvasive ventilation (NIV) versus NIV alone in patients with Acute Respiratory failure (ARF) admitted to the intensive care unit (ICU). The study will include 75 patients of both sexes, classified as ASA class Ⅰ-ⅠⅠⅠ, divided into three groups with 25 patients in each group.

Eligibility criteria

Qualifiers

Age ≥18 year of both sexes. • Diagnosed with Acute Respiratory Failure (ARF) defined as the combination of a PaO2/FiO2 ratio < 300 after 15 minutes of conventional oxygen delivered through a face mask, with a FiO2 at least of 50% and respiratory rate > 30 breaths/min.

Disqualifiers

Chronic respiratory disease

Cardiogenic pulmonary edema

Life-threatening arrythmias

Hemodynamic instability requiring vasopressors

Trial design

Treatments tested in this trial

  • HFNC
  • NIV

Treatment groups

75 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Minia University

Lead sponsor

Minia University Hospital

Collaborator